Agios Pharmaceuticals at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Agios Pharmaceuticals brings 3 presentations to ASH 2026 in New Orleans, and exhibits at Booth 929. Its program centres on sickle cell disease and thalassemia. It presents sessions on an oral thalassemia treatment and on hemolysis in sickle cell disease, and supports a symposium on sickle cell therapies.
| Organization | ASH 2026 Attendance |
|---|---|
Agios Pharmaceuticals Cambridge, MA | |
Commercial-stage biopharmaceutical company with roots in hematology, developing medicines for rare diseases. | Booth Exhibiting at Booth 929 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 7:00am–10:00am A Hematologist’s Guide to the Sickle Cell Disease Revolution: Genes, Activators, and Beyond Approved and emerging gene therapies and new pyruvate kinase activators for sickle cell disease, and how to match patients to each and refer them. Talk Sun Dec 13 11:30am–12:30pm Talk Sun Dec 13 4:30pm–6:00pm Talk Mon Dec 14 8:00am–9:00am |
Find decision makers at Agios Pharmaceuticals
Tell us what you sell and we’ll find the people at Agios Pharmaceuticals most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction